|
|
|
Volumn 27, Issue 3 SUPPL. 5, 2000, Pages 67-71
|
|
Pentostatin (Nipent) and high-dose cycloposphamide for the treatment of refractory autoimmune disorders
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINO 3 BROMOPYRAZOLO[3,4 D]PYRIMIDINE 1 (5 AMINO 5 DEOXYRIBOSIDE);
ALKYLATING AGENT;
CLADRIBINE;
CYCLOPHOSPHAMIDE;
FLUDARABINE;
GRANULOCYTE COLONY STIMULATING FACTOR;
METHOTREXATE;
PENTOSTATIN;
PURINE DERIVATIVE;
ANTINEOPLASTIC ACTIVITY;
AUTOIMMUNE DISEASE;
BONE MARROW SUPPRESSION;
BONE MARROW TRANSPLANTATION;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONFERENCE PAPER;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG MEGADOSE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
NEUROTOXICITY;
NONHUMAN;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
RHEUMATIC DISEASE;
RHEUMATOID ARTHRITIS;
SCLERODERMA;
STEM CELL TRANSPLANTATION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ADENOSINE DEAMINASE;
ANTIRHEUMATIC AGENTS;
AUTOIMMUNE DISEASES;
CYCLOPHOSPHAMIDE;
DRUG COMBINATIONS;
ENZYME INHIBITORS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
METHOTREXATE;
PENTOSTATIN;
PURINE NUCLEOSIDES;
RHEUMATIC DISEASES;
|
|
EID: 0033920811
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (32)
|
